ETHealthworld.com brings latest duchenne muscular dystrophy news, views and updates from all top sources for the Indian Health industry.

Atossa's Rare Pediatric Disease Designation for (Z)-endoxifen in neuromuscular diseases qualifies for a future PRV upon FDA approval SEATTLE, Feb. 5, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc.

KYOTO--Utilizing genome editing technology, a team of researchers has developed a much more effective treatment for a certain ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, announced today that the U.S. Food and Drug Administration (FDA ...

A Fond du Lac woman faces felony child neglect charges after her 12-year-old son, who had muscular dystrophy, died of ...

A GoFundMe has been launched for Liam Cusack, an Irish American journalist who is battling Multiple Myeloma, a deadly blood ...

The Information Day takes place on Saturday 28 February 2026 and is organised by the leading charity for more than 110,000 ...

A milestone in the treatment of Duchenne muscular dystrophy (DMD) passed recently with remarkably little public notice. That ...

The HFD raised $11,253 in the 2025 version of the fundraising campaign benefiting the Muscular Dystrophy Association.

Researchers described what they believe to be the first case of SMA type 4 presenting with a false enlargement of a muscle in ...

Residents of Campbell Estates in Fayette County are unable to receive mail due to GPS and mapping issues, forcing them to ...

$48.7 billion for NIH, a 1% increase that helps sustain biomedical research critical to rare disease progress. The funding includes positive policy language limiting forward funding of grants and ...